Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income	$ 56,573	$ 77,697	$ 38,332
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	8,112	8,049	7,893
Net amortization of premiums on securities	4,970	5,493	3,474
Provision (benefit) for credit losses	13,311	(8,336)	27,184
Share-based compensation	2,551	1,743	1,333
Deferred income tax (benefit) expense	(4,382)	5,218	(4,523)
Proceeds from sale of loans held for sale	31,556	81,334	97,238
Originations of loans held for sale	(24,677)	(80,281)	(93,461)
Income on company owned life insurance	(5,542)	(2,947)	(1,902)
Net gain on sale of loans held for sale	(1,227)	(2,950)	(3,858)
Net loss (gain) on investment securities	15	(71)	(1,599)
Net loss (gain) on other assets	16	(441)	61
Noncash restructuring charges against assets	1,619	392	202
Increase in other assets	(29,902)	(9,342)	(37,565)
Increase (decrease) in other liabilities	80,580	(2,596)	10,646
Net cash provided by operating activities	133,573	72,962	43,455
Cash flows from investing activities:
Purchases of available for sale securities	(75,269)	(784,064)	(396,879)
Purchases of held to maturity securities	(38,551)	(18,425)	(7,345)
Proceeds from principal payments, maturities and calls on available for sale securities	122,591	150,919	97,685
Proceeds from principal payments, maturities and calls on held to maturity securities	54,479	83,684	93,046
Proceeds from sales of securities available for sale	6,252	51,891	107,098
Proceeds from sales of securities held to maturity	0	0	52
Net loan originations	(376,251)	(90,058)	(390,932)
Purchases of company owned life insurance, net of proceeds received	(35,564)	(20,056)	(30,051)
Proceeds from surrender of company owned life insurance	25,522
Proceeds from sales of other assets	0	3,510	519
Purchases of premises and equipment	(8,369)	(9,403)	(4,264)
Cash consideration paid for acquisition, net of cash acquired	0	(1,420)	0
Net cash used in investing activities	(325,160)	(633,422)	(531,071)
Cash flows from financing activities:
Net increase in deposits	102,334	548,723	722,692
Net increase (decrease) in short-term borrowings	175,000	24,700	(270,200)
Repurchase of preferred stock	0	(43)	0
Issuance of long-term debt	0	0	35,000
Debt issuance costs	0	0	(779)
Purchases of common stock for treasury	(15,340)	(9,235)	(209)
Cash dividends paid to preferred shareholders	(1,459)	(1,460)	(1,461)
Cash dividends paid to common shareholders	(17,594)	(16,991)	(16,496)
Net cash (used in) provided by financing activities	242,941	545,694	468,547
Net (decrease) increase in cash and cash equivalents	51,354	(14,766)	(19,069)
Cash and cash equivalents, beginning of period	79,112	93,878	112,947
Cash and cash equivalents, end of period	$ 130,466	$ 79,112	$ 93,878